capecitabine has been researched along with Cardiotoxicity in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 15 (55.56) | 24.3611 |
| 2020's | 12 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Bajo, D; Duplancic, D; Gavran, I; Meter, M | 1 |
| Chen, L; Chou, C; Li, C; Ngorsuraches, S; Qian, J | 2 |
| Chernyshova, VA; Gilyarov, MY; Kolos, IP; Konstantinova, EV | 1 |
| Kwakman, JJM; Mol, L; Punt, CJA | 1 |
| Clasen, SC; Lefebvre, B; Turk, A; Vater, LB | 1 |
| Banzato, A; Bergamo, F; Berretta, M; Bidoli, E; Buonadonna, A; De Angelis, G; De Paoli, A; Guglielmi, A; Herrmann, J; Innocente, R; Lestuzzi, C; Lonardi, S; Sinagra, G; Stolfo, D; Tartuferi, L; Viel, E | 1 |
| Ålgars, A; Bärlund, M; Flygare, P; Frödin, JE; Glimelius, B; Hagman, H; Halonen, P; Heervä, E; Kallio, R; Kinos, S; Kwakman, JJM; Liposits, G; McDermott, R; O'Reilly, M; Osterlund, P; Pfeiffer, P; Punt, CJA; Ristamäki, R; Röckert, R; Salminen, T; Shah, CH; Sorbye, H; Soveri, LM; Teske, AJ; van Werkhoven, E | 1 |
| Abd El-Alim, AEF; El-Hafeez, MA; Galal, AAA; Ibrahim, HA; Khamis, T; Metwally, MMM | 1 |
| Appel, JM; Dyhl-Polk, A; Kümler, T; Lund, CM; Nielsen, DL; Schou, M; Vaage-Nilsen, M; Vistisen, KK | 1 |
| Abovich, A; Asnani, A; Dommaraju, S; Frazer, M; Godishala, A; Kanduri, J; Orbite, A; Peters, ML; Pribish, A; Raber, I; Warack, S | 1 |
| Boulmpou, A; Charalampidis, P; Giannakoulas, G; Papadopoulos, CE; Teperikidis, E; Tsavousoglou, C; Vassilikos, V | 1 |
| Baars, A; de Mol, P; Kok, WEM; Koopman, M; Kwakman, JJM; Punt, CJA; van Zweeden, AA | 1 |
| Ardalan, B; Cioffi, JH; Estes, DJ; Florou, V | 1 |
| Ambesh, P; Hollander, G; Kamholz, S; Obiagwu, C; Shani, J; Shetty, V; Zivari, K | 1 |
| Aglietta, M; Bonzano, A; Cagnazzo, C; Depetris, I; Filippi, R; Leone, F; Marino, D | 1 |
| Anwar, M; Saunders, S | 1 |
| Brell, JM; Carver, JR; Denlinger, CS; Dimond, EP; Kircher, SM; Ky, B; O'Neill, A; Upshaw, JN; Wagner, LI | 1 |
| Chakrabarti, S; Eiring, R; Finnes, H; Grothey, A; Halfdanarson, T; Hartgers, M; Lobo, R; Mitchell, J; Okano, A; Sara, J | 1 |
| Braconi, C; Chau, I; Cunningham, D; Forster, M; Gerlinger, M; Kalaitzaki, E; Khan, K; Rane, JK; Rao, S; Starling, N; Valeri, N; Watkins, D | 1 |
| Ouyang, Y; Peng, T; Tong, K | 1 |
| Bai, Y; Gao, L; Jin, X; Wu, S | 1 |
| Mahipal, A; Markey, KR; Saneeymehri, SS | 1 |
| Larsen, FO; Nielsen, DL; Polk, A; Schou, M; Shahmarvand, N; Vaage-Nilsen, M; Vistisen, K | 1 |
| Brunetti, ND; Caldarola, P; De Gennaro, L; Resta, M; Rutigliano, D; Tarantini, L | 1 |
| Berretta, M; De Paoli, A; Lestuzzi, C | 1 |
| Kok, WE; Koopman, M; Kwakman, JJ; Mol, L; Punt, CJ; Simkens, LH | 1 |
6 review(s) available for capecitabine and Cardiotoxicity
| Article | Year |
|---|---|
Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Cardiotoxicity; Fluorouracil; Humans; Incidence; Neoplasms | 2022 |
5-Fluorouracil, capecitabine and vasospasm: a scoping review of pathogenesis, management options and future research considerations.
Topics: Antineoplastic Agents; Capecitabine; Cardiotoxicity; Fluorouracil; Humans; Retrospective Studies | 2022 |
Risk Factors of Fluoropyrimidine Induced Cardiotoxicity among Cancer Patients: A Systematic Review and Meta-analysis.
Topics: Capecitabine; Cardiotoxicity; Fluorouracil; Humans; Neoplasms; Risk Factors | 2021 |
Fluoropyrimidine-induced cardiotoxicity.
Topics: Acetates; Capecitabine; Cardiotoxicity; Cardiovascular Diseases; Drug Combinations; Fluorouracil; Humans; Neoplasms; Pyrimidines; Pyrrolidines; Quinazolines; Thiophenes; Thymine; Trifluridine; Uracil; Uridine | 2018 |
Capecitabine-induced myopericarditis - A case report and review of literature.
Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Capecitabine; Cardiotoxicity; Humans; Male; Pericarditis; Rectal Neoplasms | 2019 |
Paradoxical effect of capecitabine in 5-fluorouracil-induced cardiotoxicity: A case vignette and literature review.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Capecitabine; Cardiotoxicity; Chest Pain; Colorectal Neoplasms; Fluorouracil; Humans; Male; Middle Aged; Treatment Outcome | 2016 |
21 other study(ies) available for capecitabine and Cardiotoxicity
| Article | Year |
|---|---|
An unusual case of acute myopericarditis after the first dose of capecitabine: Need for new cardioprotective strategies and risk stratification.
Topics: Capecitabine; Cardiotoxicity; Female; Fluorouracil; Heart Diseases; Humans; Middle Aged; Risk Assessment | 2021 |
Using Machine Learning Approaches to Predict Short-Term Risk of Cardiotoxicity Among Patients with Colorectal Cancer After Starting Fluoropyrimidine-Based Chemotherapy.
Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Cardiotoxicity; Colorectal Neoplasms; Decision Support Techniques; Female; Fluorouracil; Heart Diseases; Humans; Machine Learning; Male; Middle Aged; Predictive Value of Tests; Risk Assessment; Risk Factors; SEER Program; Time Factors; Treatment Outcome | 2022 |
[Capecitabine and vasospastic angina: a clinical case].
Topics: Aged; Capecitabine; Cardiotoxicity; Coronary Vasospasm; Female; Heart; Humans | 2022 |
Long-Term Safety Data on S-1 Administered After Previous Intolerance to Capecitabine-Containing Systemic Treatment for Metastatic Colorectal Cancer.
Topics: Capecitabine; Cardiotoxicity; Colonic Neoplasms; Colorectal Neoplasms; Fluorouracil; Hand-Foot Syndrome; Humans; Prospective Studies; Rectal Neoplasms | 2022 |
Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical Exercise.
Topics: Arrhythmias, Cardiac; Capecitabine; Cardiotoxicity; Exercise; Humans; Incidence; Prospective Studies | 2022 |
Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study.
Topics: Adult; Aged; Aged, 80 and over; Capecitabine; Cardiotoxicity; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Young Adult | 2022 |
Baicalein prevents capecitabine-induced heart damage in female Wistar rats and enhances its anticancer potential in MCF-7 breast cancer cells.
Topics: Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Capecitabine; Cardiotoxicity; Female; Glutathione; Heart Injuries; Humans; MCF-7 Cells; Myeloid Differentiation Factor 88; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; RNA, Messenger; Toll-Like Receptor 4 | 2023 |
Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cardiotoxicity; Colorectal Neoplasms; Denmark; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Humans; Incidence; Male; Middle Aged; Myocardial Ischemia; Retrospective Studies; Risk Factors; Young Adult | 2020 |
Fluoropyrimidine-Associated Cardiotoxicity: A Retrospective Case-Control Study.
Topics: Capecitabine; Cardiotoxicity; Case-Control Studies; Fluorouracil; Humans; Retrospective Studies | 2020 |
Case series of patients treated with the oral fluoropyrimidine S-1 after capecitabine-induced coronary artery vasospasm.
Topics: Administration, Oral; Aged; Breast Neoplasms; Capecitabine; Cardiotoxicity; Colorectal Neoplasms; Coronary Vasospasm; Drug Combinations; Drug Substitution; Female; Humans; Male; Middle Aged; Oxonic Acid; Stomach Neoplasms; Tegafur | 2017 |
Treatment of advanced colorectal cancer in a patient with cardiotoxic reactions to 5-fluorouracil and capecitabine using suboptimal doses.
Topics: Adult; Antimetabolites, Antineoplastic; Capecitabine; Cardiotoxicity; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Liver Neoplasms | 2017 |
Rapidly developing heart failure from capecitabine cardiotoxicity: a case study.
Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Cardiotoxicity; Heart Failure; Humans; Male | 2018 |
Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cardiotoxicity; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Fluorouracil; Follow-Up Studies; Heart Diseases; Humans; Incidence; Neoplasms; Prognosis; United States | 2019 |
Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cardiotoxicity; Colorectal Neoplasms; Coronary Vasospasm; Female; Fluorouracil; Follow-Up Studies; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Oxaliplatin; Prognosis; Retrospective Studies | 2019 |
Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center Experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cardiotoxicity; Cardiovascular Diseases; Female; Fluorouracil; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Prognosis; Quinazolines; Retrospective Studies; Safety; Survival Rate; Thiophenes | 2019 |
Rechallenge capecitabine after fluoropyrimidine-induced cardiotoxicity in rectal cancer: A case report.
Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Capecitabine; Cardiotoxicity; Combined Modality Therapy; Female; Fluorouracil; Humans; Liver Neoplasms; Rectal Neoplasms | 2019 |
Incidence of and risk factors for cardiotoxicity after fluorouracil-based chemotherapy in locally advanced or metastatic gastric cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cardiotoxicity; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Humans; Incidence; Lymphatic Metastasis; Male; Middle Aged; Oxaliplatin; Prognosis; Retrospective Studies; Risk Factors; Stomach Neoplasms; Survival Rate | 2019 |
Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Breast Neoplasms; Capecitabine; Cardiotoxicity; Chest Pain; Comorbidity; Denmark; Female; Humans; Incidence; Middle Aged; Myocardial Infarction; Neoplasm Metastasis; Retrospective Studies; Risk Factors | 2016 |
Cardiotoxicity of capecitabine: Captions not to bin.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Cardiotoxicity; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Early Diagnosis; Humans | 2017 |
Capecitabine cardiotoxicity: How to limit life-threatening events.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Cardiotoxicity; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Humans | 2017 |
Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Bevacizumab; Capecitabine; Carcinoma; Cardiotoxicity; Chest Pain; Colorectal Neoplasms; Heart Failure; Humans; Incidence; Myocardial Infarction; Myocardial Ischemia; Neoplasm Metastasis; Netherlands; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic; Retrospective Studies | 2017 |